TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement. December 15, 2006